$REGN Poised to Cash In on Presidential Treatment
Regeneron Pharmaceuticals, Inc.NASDAQ
Description
⋅ REGN just got a big boost of exposure with Trump's treatment as a coming-out party.
The stock just held range support and broke up through sloped resistance. A move above the 50-day is likely on tap for today.